BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 2461800)

  • 1. Significance of purine salvage in circumventing the action of antimetabolites in rat hepatoma cells.
    Natsumeda Y; Ikegami T; Olah E; Weber G
    Cancer Res; 1989 Jan; 49(1):88-92. PubMed ID: 2461800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo guanylate synthesis in the commitment to replication in hepatoma 3924A cells.
    Natsumeda Y; Ikegami T; Murayama K; Weber G
    Cancer Res; 1988 Feb; 48(3):507-11. PubMed ID: 3121175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.
    Natsumeda Y; Prajda N; Donohue JP; Glover JL; Weber G
    Cancer Res; 1984 Jun; 44(6):2475-9. PubMed ID: 6327016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage capacity of hepatoma 3924A and action of dipyridamole.
    Weber G; Lui MS; Natsumeda Y; Faderan MA
    Adv Enzyme Regul; 1983; 21():53-69. PubMed ID: 6443595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gout and the regulation of purine biosynthesis.
    Hershfield MS; Seegmiller JE
    Horiz Biochem Biophys; 1976; 2():134-62. PubMed ID: 776767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulation of purine nucleotide biosynthesis in mutant Saccharomyces cerevisiae yeasts with increased sensitivity of the pathway for de novo synthesis to inhibition by exogenous guanine].
    Smolina VS; Andrianova VM; Bekker ML
    Genetika; 1978 Sep; 14(9):1495-1502. PubMed ID: 214373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine metabolism of human glioblastoma in vivo.
    Pillwein K; Chiba P; Knoflach A; Czermak B; Schuchter K; Gersdorf E; Ausserer B; Murr C; Goebl R; Stockhammer G
    Cancer Res; 1990 Mar; 50(5):1576-9. PubMed ID: 2154328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targets and markers of selective action of tiazofurin.
    Weber G; Natsumeda Y; Pillwein K
    Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
    Prajda N; Hata Y; Abonyi M; Singhal RL; Weber G
    Cancer Res; 1993 Dec; 53(24):5982-6. PubMed ID: 7903199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
    Weber G; Natsumeda Y; Lui MS; Faderan MA; Liepnieks JJ; Elliott WL
    Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical effect of three different inhibitors of purine/pyrimidine metabolism on differentiation in HL60 cells.
    Ahmed N; Weidemann MJ
    Leuk Res; 1995 Apr; 19(4):263-73. PubMed ID: 7538618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin regulatory effects on purine- and pyrimidine metabolism in alloxan diabetic rat liver.
    Pillwein K; Reardon MA; Jayaram HN; Natsumeda Y; Elliott WL; Faderan MA; Prajda N; Sperl W; Weber G
    Padiatr Padol; 1988; 23(2):135-44. PubMed ID: 3043317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.
    Lucas DL; Webster HK; Wright DG
    J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine enzymology of human colon carcinomas.
    Natsumeda Y; Lui MS; Emrani J; Faderan MA; Reardon MA; Eble JN; Glover JL; Weber G
    Cancer Res; 1985 Jun; 45(6):2556-9. PubMed ID: 3986794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Brosh S; Boer P; Kupfer B; de Vries A; Sperling O
    J Clin Invest; 1976 Aug; 58(2):289-97. PubMed ID: 956368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot GJ; Jayaram HN; Lapis E; Natsumeda Y; Nichols CR; Kneebone P; Heerema N; Weber G; Hoffman R
    Cancer Res; 1989 Jul; 49(13):3696-701. PubMed ID: 2567208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo GMP synthesis is required for axon guidance in Drosophila.
    Long H; Cameron S; Yu L; Rao Y
    Genetics; 2006 Mar; 172(3):1633-42. PubMed ID: 16322525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiazofurin: molecular and clinical action.
    Weber G; Prajda N; Abonyi M; Look KY; Tricot G
    Anticancer Res; 1996; 16(6A):3313-22. PubMed ID: 9042306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of resistance to tiazofurin in hepatoma 3924A.
    Jayaram HN; Pillwein K; Lui MS; Faderan MA; Weber G
    Biochem Pharmacol; 1986 Feb; 35(4):587-93. PubMed ID: 2868729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some regulatory and integrative aspects of purine nucleotide biosynthesis and its control: an overview.
    Watts RW
    Adv Enzyme Regul; 1983; 21():33-51. PubMed ID: 6152730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.